The High Dividend Yield Vanguard ETF (NYSEARCA:VYM) has surged by more than 6% month-over-month, suggesting that dividend stocks are regaining traction. Intuitively speaking, the resurgence does make sense as a pending interest rate pivot may initiate more confidence among dividend investors. I say this because stocks with high dividend payout ratios usually suffer during high interest rate environments.

After many, if not most, growth stocks tumbled over the last two and a half years, I can certainly understand why investors would want to include many safe stocks in their portfolios. Further, a majority of the Magnificent Seven stocks are quite high at this point, so buying and holding them entails significant amounts of

About wealth creation, the playbook of millionaires is shrouded in secrecy, revealing tantalizing glimpses into their investment strategies. Picture this: behind the closed doors of financial fortresses, a select few are unleashing a different game, navigating millionaire stocks with precision and insight. The article dives into the heart of the first one, discovering a company

While we’re not in a bull market, certain value penny stocks show potential for 5x or 10x returns in the next five years, assuming forecasted business catalysts unfold. If we’re focusing on promising early-stage businesses, the long-term outlook is optimistic. Discussing penny stocks with a 12-month return potential of 100% may seem conservative, considering the

Blue chip stocks are generally a strong investment for any stage of the economic cycle and tend to take advantage of overarching trends. That remains as true today as it was yesterday and will be tomorrow. Today’s economy is marked by a lot of unsteadiness. Prices and inflation continue to be high but appear to be

Cybersecurity has been around for several years and will continue to be one of the fastest growing sectors. In addition to strong demand, these products command high margins. That’s why it’s time for investors to leave room for cybersecurity stocks in their portfolio.   Recent growth has been spurred by the emergence of artificial intelligence

Starting out as an investor can be intimidating. As legendary investor Warren Buffett put it, there are two important rules to follow: One, don’t lose money. And two, remember rule number one. Of course, this is easier said than done, especially with hundreds of stocks to choose from. Often times, one can be left with

Rapper Snoop Dogg announced on Nov. 17 that he was giving up smoking cannabis. Cannabis stocks fell on the news. “After much consideration & conversation with my family, I’ve decided to give up smoke. Please respect my privacy at this time,” Newsweek reported Snoop Dogg’s comments from X and Instagram.  As anyone who’s followed cannabis

The primary argument for a labor market rebound is that the recession of 2023 hasn’t emerged as planned. In typical fashion, many economists and market analysts are simply kicking the can down the road and calling for a recession sometime in 2024. Like a broken clock, they may be right.   Who knows? Right now, the

Over the past year, consumers have shifted their spending preferences from goods to services. After a two-year slump due to the pandemic, travel has rebounded strongly and is approaching pre-pandemic levels. This shift has benefited top-rated stocks in the travel industry. After solid air travel growth in 2022, consumers have continued to splurge on travel

Large and mega-caps like Nvidia (NASDAQ:NVDA) occasionally turn into multibagger stocks even after breaking into the big leagues. But this isn’t common. More often than not, finding true multibagger stocks to buy is a matter of identifying promising, beaten-down small-cap stocks with enormous upside potential. But, paradoxically, these same companies are often either unprofitable or

Some of the hottest opportunities can be found in biotech stocks. Look at gene editing companies, like CRISPR Therapeutics (NASDAQ:CRSP), for example. Since the start of November, CRSP ran from about $40 to $70.60 on a favorable US FDA advisory panel review of its sickle cell treatment. Now, as it nears its Dec. 8 PDUFA date it could

I’ve been guilty over the last several years of creating an us versus them situation regarding Advance Micro Devices (NASDAQ:AMD) and Nvidia (NASDAQ:NVDA). While I’m partial to the latter, owning AMD stock is not wrong. Not by a long shot.  InvestorPlace contributor Dana Blankenhorn recently discussed why he still owns AMD. He pointed out that

The world has continuously demanded technology. Hence, electric vehicle (EV) companies have experienced increased demand in the past few years. The increasing sales of electric vehicles are an evident manifestation of such a demand. Over 6 million new battery electric vehicles (BEV) and plug-in hybrids (PHEV) were sold in the first half of 2023 in